Pimobendan 74150-27-9 Metabolism PDE inhibitor
Biya:T/T, L/C
Asalin samfur:China
Tashar Jirgin Ruwa:Beijing/Shanghai/Hangzhou
Oda (MOQ):1 g
Lokacin Jagora:3 kwanakin aiki
Ƙarfin samarwa:1kg/wata
Yanayin ajiya:Ajiye a wuri mai sanyi, busasshiyar wuri, zazzabin ɗaki.
Kunshin kayan:kwalba, kwalba
Girman kunshin:1g / gwangwani, 5/kwali, 10g/kwali, 50g / kwalban, 500g / kwalban
Bayanin aminci:UN 2811 6.1/PG 3
Gabatarwa
Pimobendan, maganin dabbobi ne.Yana da mai ilimin calcium kuma mai zaɓin mai hanawa na phosphodiesterase 3 (PDE3) tare da ingantaccen tasirin inotropic da vasodilator.
Ana amfani da Pimobendan wajen kula da gazawar zuciya a cikin karnuka, wanda aka fi sani da myxomatous mitral bawul cuta (wanda aka sani a baya da endocardiosis), ko dilated cardiomyopathy.Bincike ya nuna cewa a matsayin monotherapy, pimobendan yana ƙaruwa lokacin rayuwa kuma yana inganta rayuwa a cikin marasa lafiya na canine tare da raunin zuciya na biyu zuwa cututtukan mitral valve idan aka kwatanta da benazepril, mai hana ACE.
Musamman (USP43)
| Abu | Ƙayyadaddun bayanai |
| Bayyanar | Farin fari ko dan kadan mai launin rawaya, hygroscopic |
| Mp | Kimanin 242 ℃ |
| Solubility | A zahiri wanda ba a iya narkewa cikin ruwa, mai narkewa cikin yardar kaina a cikin dimethylformamide, mai narkewa a cikin acetone kuma cikin methanil. |
| Ganewa | Infrared absorption spectrophotometry, Kwatanta pimobendan CRS. |
| Lokacin riƙewa na babban kololuwar mafita na Samfurin ya yi daidai da na daidaitaccen bayani na hannun jari, kamar yadda aka samu a cikin gwajin ƙazantattun kwayoyin halitta. | |
| Karfe masu nauyi | ≤10pm |
| Granularity | P90 ≤ 25μm |
| Girman barbashi | 20-80 guda |
| Ragowar kaushi | ≤ 500ppm |
| Ruwa | ≤ 1.0% |
| Assay | 98.0% ~ 102.0% |
| Sulfate ash | 0.10% |
| Abubuwan da ke da alaƙa (HPLC) | |
| rashin tsarki A | 0.10% |
| rashin tsarki B | 0.10% |
| Duk wani kazanta | 0.10% |
| Jimlar ƙazanta | 0.20% |
